EBV infection is a very common viral infection worldwide and has been implicated in various malignancies including lymphomas, gastric cancer, and nasopharangeal cancer. Patients with EBV positive PTLD and NK/T-cell lymphoma tend to have a better prognosis than EBV negative patients. On the other han In the treatment of Epstein-Barr virus (EBV)-related lymphomas, there are few therapies specifically targeted against the latent virus within these tumors; in most cases the treatment approach is not different than the approach to EBV-negative lymphomas. Nonetheless, current and emerging therapies focused on exploiting aspects of EBV biology may.
The most common cause of myocarditis is viral infection, including Epstein-Barr virus (EBV). Nevertheless, EBV rarely presents with cardiac involvement in immunocompetent hosts. We report a case of acute EBV-related myocarditis in a young female, complicated with malignant ventricular arrhythmias and cardiac arrest Epstein-Barr virus (EBV) is associated with multiple types of human cancer, including lymphoid and epithelial cancers. The closest association with EBV infection is seen in undifferentiated nasopharyngeal carcinoma (NPC), which is endemic in the southern Chinese population
Epstein-Barr virus-related post-transplant lymphoproliferative disorder (EBV-PTLD) is a rare but life-threatening complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). T-cell immunodeficiency after transplantation and EBV primary infection/reactivation play major roles in the pathogenesis Epstein-Barr virus-associated lymphoproliferative diseases (also termed EBV-associated lymphoproliferative diseases or EBV+ LPD) are a group of disorders in which one or more types of lymphoid cells (a type of white blood cell), i.e. B cells, T cells, NK cells, and histiocytic-dendritic cells, are infected with the Epstein-Barr virus (EBV) Epstein-Barr virus (EBV), also known as human herpesvirus 4 (HHV-4), is one of the eight known lymphotropic herpesviruses . EBV most commonly causes infectious mononucleosis, also known as glandular fever, which is characterised by fever, sore throat, and lymphadenopathy . Most individuals are exposed to EBV during the first few decades of.
EBV nuclear antigen (EBNA) Antibody to EBNA, determined by the standard immunofluorescent test, is not seen in the acute phase of EBV infection but slowly appears two to four months after onset of symptoms and persists for the rest of a person's life. Other EBNA enzyme immunoassays may report false positive results The Epstein-Barr virus (EBV), formally called Human gammaherpesvirus 4, is one of the nine known human herpesvirus types in the herpes family, and is one of the most common viruses in humans. EBV is a double-stranded DNA virus. It is best known as the cause of infectious mononucleosis (mono or glandular fever) , EBV is associated with lymphoproliferation, and may contribute to the development of lymphoproliferative diseases (EBV-LPD), including B-cell non-Hodgkin lymphomas (NHL), Hodgkin's lymphoma (HL), NK/T−cell, and peripheral T cell lymphomas ( 2 - 6 )
2. Ebstein Barr Virus • Formerly designated human herpesvirus type 4 (HHV-4) • Michael A. Epstein and Yvonne Barr were the first identify EBV in tumor tissue associated with Burkitt's Lymphoma • Gamma 1 subtype of the subfamily ammaherpesvirinae. • Infects 95% population within first four decades of life. 3 . Infectious mononucleosis, also called mono, is a contagious disease. Epstein-Barr virus (EBV) is the most common cause of infectious mononucleosis, but other viruses can also cause this disease. It is common among teenagers and young adults, especially college students Epstein-Barr virus (EBV) is a member of the herpesvirus family that can infect humans. EBV infections are very common — you've probably already contracted the virus without even knowing it. The..
Epstein-Barr virus (EBV) is detected in some Hodgkin lymphoma (HL) tumor cells. Primary infection is associated with infectious mononucleosis and EBV + HL. Vaccines and antiviral drugs show promise in modulating the clinical course of infectious mononucleosis. Their impact on HL is entirely unknown EBV-Related Hodgkin Lymphoma; EBV-Related Non-Hodgkin Lymphoma. EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified. Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; EBV-Related Burkitt Lymphoma. Endemic Burkitt Lymphoma; Grade III Lymphomatoid Granulomatosi
(A) In EBV-HLH, the viral infection causes a hyperinflammatory interaction with T cells and macrophages, resulting in excessive production of interferon-γ (IFNγ), tumor necrosis factor α (TNFα), interleukin-1 (IL-1), and other cytokines leading to HLH Epstein-Barr virus (EBV), a widespread human herpes virus, can cause mononucleosis — but usually it doesn't. In fact, most EBV infections aren't noticeable, even when they're most active in your body. By age 35, almost everyone has antibodies to EBV, indicating past infection. It takes more than an uncovered cough or sneeze to transmit EBV
NPC is related to Epstein-Barr virus (EBV) infection which can promote the development of NPC [ 5 ]. The detection of specific Epstein-Barr virus DNA and antibodies are important means for the early diagnosis of NPC [ 6 ]. In addition, EBV-based antibodies detection has the advantages of rapid, convenient, and low cost Symptoms of EBV-related infectious mononucleosis Most people contract the Epstein-Barr virus, or EBV, during childhood and may not show symptoms during that time. Children may show only very mild or non-specific symptoms of infection, but the condition tends to affect teenagers and adults more severely. [3 Epstein-Barr virus (EBV) is a member of the herpes virus family and affects patients worldwide. 1 While more than 90% of adults have been infected with EBV over the course of their lives, they remain asymptomatic, and most primary infections occur in infants and children. 2 As manifestations of EBV in the gastrointestinal tract almost always occur in states of immunodeficiency, EBV-induced colitis in immunocompetent individuals is extremely rare
Epstein-Barr virus (EBV) lymphoproliferative disease (LPD) is the result of the outgrowth of EBV-infected B cells that would normally be controlled by an effective EBV-specific cytotoxic T-cell response. LPD may occur during both primary and secondary immune deficiencies and even in some persons without documented immunodeficiency Epstein-Barr virus (EBV) is a ubiquitous virus that infects at least 95% of the population. Most persons are infected during infancy and early childhood and are asymptomatic or have nonspecific symptoms ().Infection of adolescents and young adults with EBV often results in infectious mononucleosis with fever, lymphadenopathy, sore throat, and splenomegaly EBV is a member of the herpesvirus family. As with other herpesviruses, EBV is an enveloped virus that contains a DNA core surrounded by an icosahedral nucleocapsid and a tegument As EBV-related hepatitis is a frequent finding, liver function tests were performed, excluding disease based on normal results both on admission and discharge. Therapy with IV steroids (methylprednisolone 40 mg BID) was started
EBV was found to be associated with the worst outcome (73% mortality) . In retrospective studies, high EBV-DNA viral load (>1,000 copies/mL), hyperbilirubinemia (>1.8 mg/dL), and highly elevated ferritin level (>20,300 ng/mL) were proposed as factors associated with poor outcome in patients with EBV-related HLH [26, 27]. Our patient had at. Rather than intertwining with host DNA, EBV DNA binds to the surface of the host DNA in a way that makes the molecule change shape, and that turns on cancer-related genes nearby, study author. The Epstein-Barr virus test is a blood test that determines if your body is producing antibodies and mounting an immune response against EBV [ 2 ]. It is also known as the Epstein-Barr virus antibody profile. If you have the virus, your body will produce different types of antibodies to help combat the infection EBV-related lymphomas are a heterogeneous group of hematologic malignancies but share the feature of harboring latent EBV within tumor cells. Certain lymphomas, such as endemic BL or HIV-associated primary central nervous system lymphoma, are EBV-positive in virtually 100 % of cases Hypothetical scenario: EBV and HLA lass II variants in MS. EBV infection of B cells may provoke an immune response in which HLA class II alleles are central in presenting EBV antigens to CD4 + T cells, which ultimately is important in the viral defense through CD8 + cells and antibodies. HLA-DR15 can provide a poor class II-mediated activation of the CD4 + response, with ensuing higher viral.
The Epstein-Barr virus (EBV) -- best known for causing mononucleosis -- also increases the risks for some people of developing seven other major diseases, according to a new study. The diseases. . EBV is closely related to the lymphocryptoviruses (LCVs) present in Old World nonhuman primates, including EBV-like viruses of chimpanzees and rhesus monkeys
Post-transplant lymphoproliferative disorder (PTLD) is a severe complication of solid organ transplantation that can be classified into two major subtypes, namely, early lesions and non-early lesions, based on histopathological findings. In the vast majority of cases, proliferating cells are B lymphocytes and, most frequently, proliferation is induced by Epstein-Barr virus (EBV) infection Epstein-Barr virus (EBV) is a virus that typically causes a mild to moderate illness. Blood tests for Epstein-Barr virus detect antibodies to EBV in the blood and help establish a diagnosis of EBV infection.. Epstein-Barr virus causes an infection that is very common. According to the Centers for Disease Control and Prevention (CDC), most people in the United States are infected by EBV at some.
The objective of this analysis was to investigate prognostic factors that influence the outcome of Epstein-Barr virus (EBV)-related posttransplant lymphoproliferative disorder (PTLD) after a rituximab-based treatment in the allogeneic hematopoietic stem cell transplant (HSCT) setting. Methods Therapeutic strategies and indications of Radiotherapy (RT) in EBV related lymphoproliferative disorders . Int J Fam Commun Med. 2018;2(2):83 - 84. DOI: 10.15406/ijfcm.2018.02.00042. Download PDF. Opinion. The Epstein-Barr virus (EBV) is a member of the gamma-herpesvirus family and is also called human herpesvirus-4. It is recognized as the. Still, EBV infection rarely leads to NPC, so other factors probably play a role in whether or not it causes cancer. For instance, eating a diet high in salt-cured fish and meat seems to increase the ability of EBV to cause NPC. Studies show that foods preserved in this way may produce chemicals that can damage DNA. The damaged DNA then alters a. EBV-related malignant lymphoproliferative diseases share common features with other aggressive lymphomas, including a high degree of extranodal involve-ment, tumor vascularization, and tumor necrosis. Cognizance of the particular underlying diseases and conditions associated with the development of EBV-related lymphoproliferativ Older patients are more susceptible to severe Epstein-Barr virus (EBV)-related infectious mononucleosis (IM). This condition may increase in industrialized countries where primary EBV infection occurs later in life. Between 1990 and 2004, 38 patients were admitted to our department with EBV-related IM. Two patients died. The annual incidence increased significantly (r = 0.623; P = 0.013)
We cannot tell whether EBV infected the smooth-muscle cells before they were transformed into leiomyosarcomas or whether EBV is causally related to the malignant transformation of the smooth. The main reservoir for EBV reactivation and development of EBV-related malignancies is the memory-B cells. Two strains, labeled EBV-1 and EBV-2 (also known as type A and type B), have been identified. Although the genes expressed during latent infection have some differences, the acute illnesses caused by the two strains are apparently. Chronic active Epstein-Barr virus infection (CAEBV) is a very rare complication of an Epstein Barr virus (EBV) infection. Symptoms of CAEBV may include fever, swollen lymph nodes, and an enlarged liver and/or spleen.More serious complications may include anemia, nerve damage, liver failure, and/or interstitial pneumonia.Symptoms may be constant or come and go, and tend to get worse over time Title:EBV-Related Malignancies, Outcomes and Novel Prevention Strategies VOLUME: 16 ISSUE: 1 Author(s):Oluwatobi Ohiole Ozoya, Lubomir Sokol and Samir Dalia Affiliation:Mercy Clinic Joplin- Oncology and Hematology, 100 Mercy Way, Joplin, MO 64804, USA. Keywords:Epstein Barr Virus, Epstein-Barr nuclear antigen (EBNA), Latent membrane protein (LMP), EBV-encoded RNAs (EBER), cancers Researchers develop dual-targeting drug for EBV-related cancers. A research team led by Professor Gary Wong Ka-Leung (center), Dr Lung Hong Lok (right) and Dr Law Ga-lai develop a novel dual.
unc.edu. The Epstein Barr virus (EBV) was the first described oncovirus (cancer causing virus), which has been associated with the development of a variety of lymphoproliferative disorders, such as Burkitt, primary CNS, NK/T-cell, plasmablastic and Hodgkin lymphoma. EBV infection occurs early in childhood, and approximately 90 to 95% of adults. Introduction Epstein-Barr virus (EBV) infections is a common early childhood infection. These infections are usually asymptomatic. Epstein-Barr virus-induced infectious mononucleosis(IM) occurs typically in young adult patients. The most common presentation of IM are fever, malaise, lymphadenopathy and sorethroat. Acute hemolytic anemia is a rare complication, occurs in only 1% to 3% of.
Age-related Epstein-Barr virus (EBV)-positive B-cell lymphoproliferative disorder (LPD) occurs in elderly patients without immunodeficiency. An 81-year-old woman without any known immunodeficiency was examined for fever, rash, arthritis, thrombocytopenia, pleural and pericardial effusions, lymphadenopathy, and positive autoantibodies, which satisfied the classification criteria for systemic. The 200 Day Milk EBV is expressed as kilograms (kg) of calf live weight at 200 days (i.e. the expected difference in the weight of the calf at 200 days due to the maternal effect (milk) of the cow). The 200 Day Milk EBV is calculated by partitioning the difference in the 200 day weight of calves into growth and milk components
EBV seropositive COVID-19 patients had a 3 · 64-fold risk of having a fever symptom than EBV seronegative (95%CI, 1 · 26-10 · 51; P=0 · 02). C-reactive protein (CRP) in EBV seropositive COVID-19 patients were higher than EBV seronegative patients (P=0 · 01) EBV produces miRNAs with important functions in cancer growth, tumor invasion and host immune surveillance. The discovery of EBV miR-BARTs is recent, and most of their functions are still unknown. Nonetheless, some new studies underline their key roles in EBV-associated malignancies. In EBV-associated tumors, the expression profile of miR-BARTs varies according to the cell type, autophagic. The Epstein-Barr virus (EBV) activates the retrovirus HERV-W/MSRV in patients with infectious mononucleosis. This activation has been found to be associated with multiple sclerosis.. Bebo said. Glandular fever is an infection caused by the Epstein Barr virus (EBV). It is also called Infectious Mononucleosis and sometimes the 'kissing disease'. Once a person catches Epstein Barr virus, it is believed that the virus remains in his or her body for life, though it usually does not cause further illness The Epstein-Barr virus (EBV) was discovered 36 years ago by electron microscopy of cells cultured from Burkitt's lymphoma tissue by Epstein, Achong, and Barr.1 Four years later, in 1968, EBV was.
Epstein-Barr virus (EBV) is an etiological factor for most lymphoproliferative disorders. EBV infects 90% of people during their lives 4). Epstein Barr Virus (EBV) presumably spreads by saliva or droplets. It has an incubation period of 4 to 5 weeks Epstein-Barr virus (EBV) is an ubiquitous herpesvirus with a tropism for epithelial cells (where lytic replication occurs) and B-cells (where latency is maintained). EBV persists throughout life and chronic infection is asymptomatic in most individuals. However, immunocompromised patients may be unable to control EBV infection and are at increased risk of EBV-related malignancies, such as. Epstein‐Barr virus (EBV) is carried in the blood of most adults, and transfusion‐related infections have been reported. EBV is particularly deleterious in immunosuppressed transplant patients. The aim was to determine if EBV transmission occurred through leukodepleted blood product transfusion in pediatric recipients of hematopoietic stem. Epstein-Barr virus (EBV)-related B-cell lymphomas are fatal complications of immunosuppression due to AIDS, organ transplantation or congenital immune abnormalities. The malignant cells. The primary end point of the study was the incidence of EBV-related complications, including EBV reactivation and/or EBV-PTLD. Crosstabs and Student's t -test were used to identify baseline.
Epstein-Barr virus (EBV) is a herpesvirus associated with lymphoid and epithelial malignancies. Both B cells and epithelial cells are susceptible and permissive to EBV infection. However, considering that 90% of the human population is persistently EBV-infected, with a minority of them developing cancer, additional factors are necessary for tumor development Epstein-Barr is the virus that causes mononucleosis. You might know this disease better by its nickname, mono. It's also called the kissing disease because of one way you can spread it to. Epstein-Barr virus (EBV), also known as human herpes virus 4, is a widely disseminated double stranded DNA herpesvirus. It is the causative agent of infectious mononucleosis (mono or glandular fever). Since the 1800s, infectious mononucleosis has been recognized as a clinical syndrome consisting of fever, pharyngitis, and adenopathy This alone does not mean you have a chronic condition related to EBV. But as I mentioned, if it is very high, then it is a red flag, and you want to dig a little deeper. EBNA IgG flares up only around/after the two first months of initial infection—this antibody also tends to stay elevated for the rest of your life Epstein-Barr virus (EBV) is prevalent among healthy individuals, and is implicated in numerous reactive and neoplastic processes in the immune system. The authors originally identified a series of senile or age‐related EBV‐associated B‐cell lymphoproliferative disorders (LPD) bearing a resemblance to immunodeficiency‐associated ones
1. Al Hamed R, Bazarbachi AH, Mohty M. Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities. Bone Marrow Transplant. (2019). doi: 10.1038/s41409-019-0548-7. [Epub ahead of print] Prevention and Treatment of EBV-Related Complications. 1. Nephrology Transplantation Department, INSERM UMR_S 1109 Strasbourg University Hospital Strasbourg France. 2. Department of Pediatrics and Surgery, Division of Infectious Diseases University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh Pittsburgh USA
Abstract: Epstein-Barr virus-related post-transplant lymphoproliferative disorder (EBV-PTLD) is a rare but life-threatening complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). T-cell immunodeficiency after transplantation and EBV primary infection/reactivation play major roles in the pathogenesis Association with Epstein-Barr virus (EBV) is less frequent in NS (10% to 40%) than in MC (∼75% of cases) cHL. 1, 14, 15 The varying frequency of association of cHL with EBV infection is probably related to different levels of patient immunosuppression. 16 One of the main features characterizing HIV-associated cHL is its strong association with EBV infection. 17 In fact, virtually all these. mmunoglobulin M autoantibody with anti-i specificity. Acute Epstein-Barr virus infection was confirmed by serologic and molecular methods. She recovered uneventfully after a 3-week course of methylprednisolone. Epstein-Barr virus infection should be considered in any case of hemolytic anemia associated with hepatic dysfunction, especially when direct antiglobulin test is positive for C3d. In.
Background Epstein-Barr virus (EBV) targets B-cells where it establishes a latent infection. EBV can transform B-cells in vitro and is recognized as an oncogenic virus, especially in the setting of immune compromise. Indeed, immunodeficient patients may fail to control chronic EBV infection, leading to the development EBV-driven lymphoid malignancies. Ataxia telangiectasia (AT) is a primary. Epstein-Barr virus (EBV) reactivation and related lymphoproliferative diseases (EBV- LPD) with high mortality rates are frequently reported after solid organ and hematopoietic transplantation.4-7 Among solid organ trans-plant recipients in Europe and the USA, over 80% of recipients with post-transplantation LPD presented with an EBV infection.8 EBV infections are usually asymptomatic with 90-95% of people by age 18 becoming seropositive. EBV is known have many different clinical presentations which can be reviewed here. A monospot test for EBV can be falsely positive and reasons for this can be reviewed here. Gastrointestinal problems related to EBV include These entities need however to be further characterized as no clear pathological definition and distinction between EBV related GZL and EBV related DLBCL are proposed in the literature. After primary infection that occurs in almost 80% of young adult population in western country, EBV latency state settles in a small portion of B cells
Pediatr Blood Cancer 2009;53:1329-1331 BRIEF REPORT Post-Transplant EBV-Related Lymphoproliferative Disorder Complicating Umbilical Cord Blood Transplantation in Patients of Adrenoleukodystrophy 1 Frankie Wai Tsoi Cheng, Vincent Lee, MRCP,1 Ka Fai To, FRCP,2 K.C. Allen Chan, MRCPCH, * FRCPA, 3 Ming Kong Shing, MRCP,1 and Chi Kong Li, MD1 EBV-associated post-transplant lymphoproliferative. The success of T‐cell transfer in 3/3 patients treated with EBV‐related PTLD, as compared to the 40% failure rate of adoptive T‐cell therapy in haplo‐HSCT recipients with CMV disease , may be related to the fact that EBV CTL are prevalently of CD8 phenotype, the subset that mediates clearance of virally infected cells, while Perruccio. Epstein-Barr virus (EBV)-related DNA was used as a model analyte, which associated with several malignancies as Hodgkin's disease, Burkitt's lymphoma and nasopharyngeal carcinoma (Balvedi et al., 2014). The strategy achieves ultrasensitive detection of EBV-related DNA with excellent specificity, which holds a great potential for early diagnosis. The EBV IoT smart, secure, connected - everywhere. Strictly speaking, the Internet of Things (IoT) is not a new venture for EBV Elektronik. EBV has, for many years, been working on topics which are now specific to IoT or directly associated with it, but which were not classified as IoT before the term was coined
The prime reason we are interested in Epstein-Barr virus (EBV)-related cancers is that the nasopharyngeal carcinoma has a high incidence in southern China (including Hong Kong) and its development stems from EBV infection Abstracts Not Selected for Presentation. EBV Related Transformation Events in CLL. EBV-related diseases in immunocompetent hosts. Unlike posttransplant lymphoproliferative disorders, which constitute a highly immunogenic lymphoproliferation whose onset is greatly favored by the host immunodeficiency status, other EBV-related diseases can arise in immunocompetent patients Epstein-Barr virus (EBV) is a ubiquitous virus detected in up to 95% of the general population. Most people are asymptomatic, while some may develop a wide range of EBV-associated lymphoproliferative disorders (LPD). Among them, EBV-positive T/NK LPD are uncommon diseases defined by the proliferation of T- or NK-cells infected by EBV. The 2017 World Health Organization (WHO) classification.
Epstein-Barr virus (EBV) antibodies are a group of tests that are ordered to help diagnose a current, recent, or past EBV infection. EBV is a member of the herpes virus family. Passed through the saliva, the virus causes an infection that is very common. According to World Health Organisation (WHO), as many as 95% of people in the world adult. EBV-related serological biomarkers for nasopharyngeal cancer remain a hot topic. The pathogenic role of Epstein-Barr virus (EBV) for the initiation and progression of nasopharyngeal carcinoma (NPC) has been highly investigated since EBV-DNA was identified in an NPC tumor specimen (1)
Quantify Epstein-Barr virus (EBV) viral load as an aid in monitoring EBV-related disease. Mnemonic Unique test identifier. EBV QNT. Methodology Process(es) used to perform the test. Quantitative Polymerase Chain Reaction. Performed Days of the week the test is performed. Sun-Sat. Reporte Epstein-Barr virus (EBV) has been associated with primary central nervous system lymphoma and other EBV-related malignancies in HIV infected patients, and detection of EBV DNA in cerebrospinal fluid (CSF) by polymerase chain reaction (PCR) has bee The number of reported cases of smooth muscle tumor (SMT) arising in patients with AIDS has been increasing since the mid-1990s. The aim of this study is to characterize the epidemiology, clinical manifestations, pathologic features, prognosis and, management of Epstein-Barr virus-related SMT (EBV-SMT) in patients with AIDS. An English language literature search identified 53 articles. Many college students know it as the virus that causes the kissing disease, or mono (mononucleosis.) But the Epstein-Barr virus (EBV) may also increase the risk of lupus and six other.
EBV produces miRNAs with important functions in cancer growth, tumor invasion and host immune surveillance. The discovery of EBV miR-BARTs is recent, and most of their functions are still unknown. Nonetheless, some new studies underline their key roles in EBV-associated malignancies. In EBV-associated tumors, the expression profile of miR-BARTs varies according to the cell type, autophagic. Nivolumab in combination with paclitaxel showed clinical activity and a manageable safety profile when used as second-line therapy for patients with Epstein-Barr virus-related, microsatellite. A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to become a next-generation treatment for cancers associated with Epstein-Barr virus (EBV) The pathogenesis of HIV-related PCNSL is strongly related to Epstein-Barr virus (EBV) infection, similar to other HIV-related lymphomas. This is described in more detail separately. (See HIV-related lymphomas: Epidemiology, risk factors, and pathobiology, section on 'Pathobiology' .) A variety of evidence demonstrates that EBV infection is. AMA Style. Bologna M, Corino V, Calareso G, Tenconi C, Alfieri S, Iacovelli NA, Cavallo A, Cavalieri S, Locati L, Bossi P, Romanello DA, Ingargiola R, Rancati T, Pignoli E, Sdao S, Pecorilla M, Facchinetti N, Trama A, Licitra L, Mainardi L, Orlandi E. Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers. A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the.